Edwards Lifesciences
(NYSE) EW
Edwards Lifesciences Financials at a Glance
Market Cap
$46.51B
Revenue (TTM)
$6.07B
Net Income (TTM)
$1.07B
EPS (TTM)
$1.81
P/E Ratio
44.33
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$80.07
Volume
0
Open
$80.05
Price
$80.07
Volume
0
Open
$80.05
Previous Close
$80.07
Daily Range
$77.60 - $80.49
52-Week Range
$65.94 - $87.89
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$80.07
Volume
0
Open
$80.05
Previous Close
$80.07
Daily Range
$77.60 - $80.49
52-Week Range
$65.94 - $87.89
EW News
EW: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Edwards Lifesciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
16,000
CEO
Bernard J. Zovighian, MBA
Website
www.edwards.comHeadquarters
Irvine, CA 92614, US
EW Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
27%
Net Income Margin
18%
Return on Equity
10%
Return on Capital
14%
Return on Assets
8%
Earnings Yield
2.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$46.51B
Shares Outstanding
580.80M
Volume
0
Short Interest
0.00%
Avg. Volume
4.60M
Financials (TTM)
Gross Profit
$4.74B
Operating Income
$1.64B
EBITDA
$1.43B
Operating Cash Flow
$1.60B
Capital Expenditure
$260.20M
Free Cash Flow
$1.33B
Cash & ST Invst.
$4.23B
Total Debt
$705.40M
Edwards Lifesciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.57B
+13.3%
Gross Profit
$1.23B
+12.4%
Gross Margin
78.30%
N/A
Market Cap
$46.51B
N/A
Market Cap/Employee
$2.94M
N/A
Employees
15,800
N/A
Net Income
$91.20M
-76.3%
EBITDA
$133.10M
-72.5%
Quarterly Fundamentals
Net Cash
$3.52B
+7.5%
Accounts Receivable
$912.10M
+25.4%
Inventory
$1.13B
+3.6%
Long Term Debt
$680.90M
+0.6%
Short Term Debt
$24.50M
+4.7%
Return on Assets
7.81%
N/A
Return on Invested Capital
13.64%
N/A
Free Cash Flow
$353.50M
+299.4%
Operating Cash Flow
$450.90M
+453.6%